Fennec Pharmaceuticals Inc (FENC)

Apr 07, 2025

(FRX) Advanced Trading Insights (FRX:CA) - news.stocktradersdaily.com

Apr 07, 2025

Apr 06, 2025

(FENC) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Apr 06, 2025

Apr 06, 2025

Breakeven Is Near for Fennec Pharmaceuticals Inc. (NASDAQ:FENC) - Yahoo Finance

Apr 06, 2025

Apr 04, 2025

Fennec Pharmaceuticals director Raykov Rosty sells $52,500 in shares - Investing.com India

Apr 04, 2025

Apr 02, 2025

Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World

Apr 02, 2025

Apr 01, 2025

Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average – Should You Sell? - Defense World

Apr 01, 2025

Apr 01, 2025

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Apr 01, 2025

Mar 27, 2025

(FENC) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 27, 2025

Mar 26, 2025

Fennec Pharmaceuticals Achieves Strong Growth and Expands Market Reach in 2024 - TipRanks

Mar 26, 2025

Mar 24, 2025

Long Term Trading Analysis for (FRX) (FRX:CA) - news.stocktradersdaily.com

Mar 24, 2025

Mar 19, 2025

(FRX) Stock Market Analysis (FRX:CA) - news.stocktradersdaily.com

Mar 19, 2025

Mar 16, 2025

(FENC) Technical Data - news.stocktradersdaily.com

Mar 16, 2025

Mar 15, 2025

(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com

Mar 15, 2025

Mar 14, 2025

Q1 EPS Forecast for Fennec Pharmaceuticals Raised by Analyst - Defense World

Mar 14, 2025

Mar 14, 2025

HC Wainwright Has Positive Forecast for TSE:FRX Q1 Earnings - Defense World

Mar 14, 2025

Mar 14, 2025

Wedbush Research Analysts Boost Earnings Estimates for FENC - Defense World

Mar 14, 2025

Mar 14, 2025

What is HC Wainwright’s Forecast for FENC Q1 Earnings? - Defense World

Mar 14, 2025

Mar 13, 2025

US$12.60: That's What Analysts Think Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Is Worth After Its Latest Results - Simply Wall St

Mar 13, 2025

Mar 13, 2025

Wedbush Boosts Earnings Estimates for Fennec Pharmaceuticals - Defense World

Mar 13, 2025

Mar 13, 2025

Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Mar 12, 2025

Fennec Pharmaceuticals: Strong Growth Potential with PEDMARK’s Market Expansion and Strategic Focus - TipRanks

Mar 12, 2025

Mar 12, 2025

Fennec Pharmaceuticals (NASDAQ:FENC) Receives Buy Rating from HC Wainwright - Defense World

Mar 12, 2025

Mar 11, 2025

Fennec Pharmaceuticals Reports Strong Growth Amid Challenges - TipRanks

Mar 11, 2025

Mar 11, 2025

Fennec Pharmaceuticals: Strategic Market Expansion and Financial Performance Justify Buy Rating - TipRanks

Mar 11, 2025

Mar 11, 2025

(FRX) Technical Data (FRX:CA) - news.stocktradersdaily.com

Mar 11, 2025

Mar 11, 2025

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 11, 2025

Mar 11, 2025

Rhumbline Advisers Grows Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World

Mar 11, 2025

Mar 11, 2025

Fennec Pharmaceuticals (NASDAQ:FENC) Receives “Outperform” Rating from Wedbush - Defense World

Mar 11, 2025

Mar 11, 2025

Fennec Pharmaceuticals Reports Strong 2024 Sales Growth - TipRanks

Mar 11, 2025

Mar 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView

Mar 10, 2025

Mar 10, 2025

Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Wedbush Reviews Fennec Pharmaceuticals' Q4 -March 10, 2025 at 12:48 pm EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% By Investing.com - Investing.com Canada

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% - Investing.com

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 10, 2025

Mar 10, 2025

Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts - Investing.com

Mar 10, 2025

Mar 10, 2025

Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain - Yahoo Finance

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Reports Strong 2024 Financials and Expands Global Reach - TipRanks

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 10, 2025

Mar 10, 2025

FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings - Nasdaq

Mar 10, 2025

Mar 10, 2025

Earnings Flash (FRX.TO) Fennec Pharmaceuticals Posts Q4 Revenue US$7.925 Million - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates - Nasdaq

Mar 10, 2025

Mar 10, 2025

Earnings Scheduled For March 10, 2025 - Benzinga

Mar 10, 2025

Mar 08, 2025

Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 08, 2025

Mar 07, 2025

Fennec Pharmaceuticals director Raykov sells $67,900 in stock By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 06, 2025

Fennec Pharmaceuticals director Raykov sells $67,900 in stock - Investing.com

Mar 06, 2025

Mar 06, 2025

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025 - The Manila Times

Mar 06, 2025

Mar 06, 2025

Trading (FENC) With Integrated Risk Controls - Stock Traders Daily

Mar 06, 2025

Mar 02, 2025

(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily

Mar 02, 2025

Feb 24, 2025

Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily

Feb 24, 2025

Feb 18, 2025

Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat

Feb 18, 2025